Israel Biotech Fund
Ken Somberg is a Venture Advisor at Israel Biotech Fund. Ken is also the Chief Medical Officer at TrialSpark. Dr. Somberg is a pharmaceutical executive with senior leadership experience in global pharma and contract research organizations.
He is the former CMO of Nevakar and Covance with significant prior experience at Novartis Pharmaceuticals as a global therapeutic area head in both Clinical Research (Transplantation and Immunology) and Regulatory Affairs (infectious Diseases, Transplantation, and Immunology).
This person is not in the org chart
This person is not in any teams
This person is not in any offices